NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Applovin
APP
US Stock MarketDetailed Quotes
TDOC Teladoc Health
- 10.990
- -0.190-1.70%
Close Feb 26 16:00 ET
- 9.300
- -1.690-15.38%
Pre 06:36 ET
1.91BMarket Cap-1.87P/E (TTM)
11.550High10.800Low11.30MVolume11.240Open11.180Pre Close121.85MTurnover7.01%Turnover RatioLossP/E (Static)173.41MShares15.95052wk High1.28P/B1.77BFloat Cap6.76052wk Low--Dividend TTM161.18MShs Float308.000Historical High--Div YieldTTM6.71%Amplitude6.760Historical Low10.779Avg Price1Lot Size
Teladoc Health Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.26%2.57B | -3.03%640.49M | -2.99%640.51M | -1.53%642.44M | 2.68%646.13M | 8.13%2.6B | 3.58%660.53M | 7.99%660.24M | 10.13%652.41M | 11.30%629.24M |
| Operating revenue | 12.58%2.57B | 11.60%640.49M | -4.60%555.28M | -1.53%642.44M | 2.68%646.13M | 8.49%2.28B | 71.48%573.92M | -4.80%582.07M | 10.13%652.41M | 11.30%629.24M |
| Cost of revenue | -1.15%751.27M | -2.32%188.93M | -3.34%179.75M | -1.30%188.06M | 2.33%194.54M | 2.16%760.03M | 2.41%193.42M | 0.18%185.96M | 4.42%190.54M | 1.65%190.11M |
| Gross profit | -1.31%1.82B | -3.33%451.56M | -2.85%460.76M | -1.62%454.39M | 2.84%451.59M | 10.80%1.84B | 4.07%467.1M | 11.39%474.28M | 12.68%461.87M | 16.07%439.14M |
| Operating expense | -1.26%2.03B | -0.66%493.72M | -5.94%501.13M | -3.33%503.58M | 5.27%528.67M | 8.61%2.05B | 3.29%497.02M | 8.23%532.77M | 9.99%520.9M | 13.31%502.19M |
| Selling and administrative expenses | -1.54%1.35B | 5.78%327.45M | -4.24%339.17M | -7.78%330.26M | 1.15%349.39M | 5.13%1.37B | -4.03%309.56M | 2.47%354.18M | 6.74%358.13M | 16.36%345.43M |
| -Selling and marketing expense | 0.90%910.78M | 13.38%227.45M | -5.68%224.93M | -4.98%220.71M | 2.77%237.69M | 6.10%902.63M | -1.04%200.61M | 2.10%238.46M | 4.40%232.29M | 20.50%231.28M |
| -General and administrative expense | -6.28%435.49M | -8.22%100M | -1.27%114.25M | -12.94%109.55M | -2.14%111.7M | 3.29%464.66M | -9.08%108.96M | 3.23%115.72M | 11.37%125.84M | 8.79%114.15M |
| Research and development costs | -11.83%307.27M | -14.66%76.75M | -14.13%72.38M | -12.09%76.75M | -6.43%81.39M | 4.46%348.52M | 8.45%89.94M | -0.36%84.29M | 10.94%87.31M | -0.49%86.99M |
| Depreciation amortization depletion | 10.82%373.55M | -8.20%89.52M | -5.02%89.57M | 27.96%96.57M | 40.28%97.89M | 31.65%337.07M | 28.80%97.52M | 52.08%94.3M | 27.11%75.47M | 18.41%69.78M |
| -Depreciation and amortization | 10.82%373.55M | -8.20%89.52M | -5.02%89.57M | 27.96%96.57M | 40.28%97.89M | 31.65%337.07M | 28.80%97.52M | 52.08%94.3M | 27.11%75.47M | 18.41%69.78M |
| Operating profit | 0.81%-208.79M | -40.90%-42.16M | 30.99%-40.36M | 16.67%-49.19M | -22.23%-77.08M | 7.42%-210.5M | 7.58%-29.92M | 11.99%-58.49M | 7.27%-59.04M | 2.80%-63.06M |
| Net non-operating interest income expense | 35.79%33.27M | -9.60%7.39M | 38.88%9.67M | 38.46%7.92M | 127.33%8.29M | 364.29%24.5M | 331.54%8.17M | 617.09%6.96M | 231.96%5.72M | 166.57%3.65M |
| Non-operating interest income | 21.99%57.07M | 3.82%14.23M | 21.58%15.33M | 17.43%13.57M | 56.46%13.94M | 269.12%46.78M | 111.46%13.71M | 162.46%12.61M | 843.51%11.56M | --8.91M |
| Non-operating interest expense | 6.83%23.8M | 23.62%6.85M | 0.25%5.66M | -3.20%5.65M | 7.33%5.65M | 1.54%22.28M | 20.68%5.54M | -8.18%5.65M | 4.91%5.84M | --5.26M |
| Other net income (expense) | -2,334.41%-818.13M | -269.73%-13.4M | 77.60%-1.8M | -6,083.35%-792.52M | -13.97%-10.42M | 99.75%-33.61M | 99.90%-3.62M | -17.32%-8.03M | 99.58%-12.82M | 99.86%-9.14M |
| Special income (charges) | -2,034.18%-812.1M | -17.38%-6.06M | 35.25%-4.04M | -6,180.39%-791.96M | 28.48%-10.05M | 99.72%-38.05M | 99.86%-5.16M | -18.29%-6.24M | 99.58%-12.61M | 99.79%-14.05M |
| -Less：Restructuring and merger&acquisition | -41.93%22.1M | 17.38%6.06M | -35.25%4.04M | -84.48%1.96M | -28.48%10.05M | 65.18%38.05M | -50.21%5.16M | 18.29%6.24M | 336.03%12.61M | 211.65%14.05M |
| -Less:Impairment of capital assets | --790M | --0 | --0 | --790M | ---- | --0 | --0 | --0 | --0 | ---- |
| Other non- operating income (expenses) | -235.77%-6.04M | -577.62%-7.34M | 224.94%2.24M | -171.98%-563K | -107.54%-370K | 617.46%4.45M | -12.07%1.54M | -14.07%-1.79M | 88.24%-207K | 577.76%4.91M |
| Income before tax | -352.47%-993.65M | -89.84%-48.17M | 45.44%-32.5M | -1,160.85%-833.79M | -15.54%-79.2M | 98.39%-219.61M | 99.33%-25.38M | 20.22%-59.56M | 97.87%-66.13M | 98.97%-68.55M |
| Income tax | 898.95%7.59M | -93.23%238K | 131.40%780K | 507.98%3.88M | 295.01%2.69M | 119.94%760K | 290.93%3.52M | -112.13%-2.48M | 19.87%-952K | 75.52%681K |
| Net income | -354.35%-1B | -67.56%-48.41M | 41.70%-33.28M | -1,185.22%-837.67M | -18.29%-81.89M | 98.39%-220.37M | 99.24%-28.89M | 22.32%-57.07M | 97.90%-65.18M | 98.96%-69.23M |
| Net income continuous Operations | -354.35%-1B | -67.56%-48.41M | 41.70%-33.28M | -1,185.22%-837.67M | -18.29%-81.89M | 98.39%-220.37M | 99.24%-28.89M | 22.32%-57.07M | 97.90%-65.18M | 98.96%-69.23M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -354.35%-1B | -67.56%-48.41M | 41.70%-33.28M | -1,185.22%-837.67M | -18.29%-81.89M | 98.39%-220.37M | 99.24%-28.89M | 22.32%-57.07M | 97.90%-65.18M | 98.96%-69.23M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -354.35%-1B | -67.56%-48.41M | 41.70%-33.28M | -1,185.22%-837.67M | -18.29%-81.89M | 98.39%-220.37M | 99.24%-28.89M | 22.32%-57.07M | 97.90%-65.18M | 98.96%-69.23M |
| Basic earnings per share | -338.06%-5.87 | -64.71%-0.28 | 45.71%-0.19 | -1,130.00%-4.92 | -16.67%-0.49 | 98.42%-1.34 | 99.28%-0.17 | 22.22%-0.35 | 97.92%-0.4 | 98.99%-0.42 |
| Diluted earnings per share | -338.06%-5.87 | -64.71%-0.28 | 45.71%-0.19 | -1,130.00%-4.92 | -16.67%-0.49 | 98.42%-1.34 | 99.28%-0.17 | 22.22%-0.35 | 97.92%-0.4 | 98.99%-0.42 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |